If you need more lookups,
subscriptions start at $34 USD/month.
Eric Easom Location
Menlo Park, CA, US
Eric Easom Work
2017 -now CEO and Co-Founder @
2019 -now Director, Board of Directors @ Resilient Biotics, Inc.
2018 -now Member Board Of Directors @ Chagas Disease Foundation
2009 -2017 Vice President, Neglected Diseases @
2007 -2014 Member Board of Directors @ Infectious Disease Research Institute
2010 -2013 Chair Board of Directors @ Infectious Disease Research Institute
2007 -2009 Sr. Director, Business Development and Marketing @ InteKrin Therapeutics, Inc.
2006 -2007 Director of Marketing @
2005 -2006 Director, Pharmaceutical Division @
2003 -2005 Founder and CEO @ Hope Pharmaceuicals
1990 -2003 US Brand Manager, Endcrine Business Unit and Humatrope @ Eli Lilly & Co.
1997 -2000 Corporate Business Development @ Eli Lilly & Co.
1995 -1997 Finance @ Eli Lilly & Co.
1990 -1994 Engineer, Manufacturing @ Eli Lilly & Co.
Eric Easom Education
Indiana University - Kelley School of Business
MBA (Marketing and Finance)
1995-1997
University of Louisville
Masters (Electrical Engineering)
1989-1990
University of Louisville
BS (Electrical Engineering)
1985-1989
Eric Easom Skills
Infectious Disease R&D
Biotech R&D Leadership
Non-Dilutive Fundraising
Biotechnology
Biochemistry
Business Development
Biotech BOD
Eric Easom Summary
Eric Easom, based in Menlo Park, CA, US, is currently a CEO and Co-Founder at AN2 Therapeutics, Inc.. Eric Easom brings experience from previous roles at Resilient Biotics, Inc., Chagas Disease Foundation, Anacor Pharmaceuticals and Infectious Disease Research Institute. Eric Easom holds a 1995 - 1997 MBA in Marketing and Finance @ Indiana University - Kelley School of Business. With a robust skill set that includes Infectious Disease R&D, Biotech R&D Leadership, Non-Dilutive Fundraising, Biotechnology, Biochemistry and more. Eric Easom has 2 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Eric Easom?
Find contact details for 700 million professionals.